⚠️ NOT FOR HUMAN CONSUMPTION – FOR RESEARCH PURPOSES ONLY ⚠️ Thymosin Alpha‑1 (Tα1)A synthetic 28‑amino‑acid peptide derived from prothymosin α, recognized for its potent immunomodulatory properties. It enhances immune function through the activation and maturation of immune cells and modulation of cytokine signaling pathways. Form: Lyophilized powder Purity: >98% (HPLC) Storage: Store in a cool, dry, and dark environment; long-term storage typically at –20 °C(Sources: Wikipedia – Thymosin α1 overview, PMCID comprehensive review) Research Highlights Enhances immune responses by promoting maturation of T lymphocytes, dendritic cells, and stimulating cytokine production, while engaging pattern recognition via Toll‑like receptors (e.g., TLR2, TLR9) to regulate innate and adaptive immunity.(Sources: PMC immunoregulatory review, Wikipedia – immune activation) Applied in research and clinical settings for its role as an immune enhancer in chronic viral infections, such as hepatitis B and C, and cancers—demonstrating immune restoration and therapeutic benefit in certain viral and oncological conditions.(Sources: Wikipedia – therapeutic application overview, PMCID comprehensive review) Investigated in preclinical and early clinical immune studies—including COVID‑19, sepsis, and SARS‑CoV‑2 infection models—for its capacity to modulate dendritic cell activity, reduce pro-inflammatory cytokine levels, and support adaptive immune cell function.(Sources: Immunity & Ageing study on SARS‑CoV‑2, MDPI study on viral infectious diseases) This compound is strictly intended for laboratory research use only.It is not approved for human or veterinary use, not a dietary supplement, and must not be used to diagnose, treat, cure, or prevent any disease or condition. FOR LABORATORY USE ONLY. NOT FOR HUMAN CONSUMPTION.